Bristol-Myers Squibb Co. and ZymoGenetics, Inc., on Oct. 22, 2008,
entered into a Release and License Agreement under which the
Company received a nonexclusive, worldwide license to
ZymoGenetics’s patents claiming…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.